Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene therapy injection hopes to slow ALS

NCT ID NCT07290062

First seen Jan 02, 2026 · Last updated May 19, 2026 · Updated 24 times

Summary

This early-stage study tests a single injection of a gene therapy called INS1202 for people with ALS, a disease that weakens muscles over time. The main goal is to see if it is safe and to find the best dose. About 23 adults with certain genetic types of ALS will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • USA001

    RECRUITING

    Columbia, Missouri, 65211, United States

    Contact Email: •••••@•••••

  • USA002

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Email: •••••@•••••

  • USA004

    RECRUITING

    La Jolla, California, 92037, United States

    Contact Email: •••••@•••••

  • USA006

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

    Contact Email: •••••@•••••

  • USA007

    RECRUITING

    Columbus, Ohio, 43221, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.